Therefore, here, we examined the mechanism via which the pro-angiogenic switch of TAMs is triggered in cases of ESCC, specifically focusing on the interplay among exosomal miR-301a-3p, PTEN, and the PI3K/AKT signaling pathway. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.